BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10645403)

  • 1. p53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 mutations in primary tumor and matched lymph node metastases.
    Tjebbes GW; Leppers vd Straat FG; Tilanus MG; Hordijk GJ; Slootweg PJ
    Oral Oncol; 1999 Jul; 35(4):384-9. PubMed ID: 10645403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordance of p53 status in matched primary tumours and metastases in head and neck squamous cell carcinoma patients.
    Kropveld A; van Mansfeld AD; Nabben N; Hordijk GJ; Slootweg PJ
    Eur J Cancer B Oral Oncol; 1996 Nov; 32B(6):388-93. PubMed ID: 9039222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
    Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
    Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 gene.
    Tabor MP; van Houten VM; Kummer JA; Vosjan MJ; Vlasblom R; Snow GB; Leemans CR; Braakhuis BJ; Brakenhoff RH
    Genes Chromosomes Cancer; 2002 Feb; 33(2):168-77. PubMed ID: 11793443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma.
    Koch WM; Brennan JA; Zahurak M; Goodman SN; Westra WH; Schwab D; Yoo GH; Lee DJ; Forastiere AA; Sidransky D
    J Natl Cancer Inst; 1996 Nov; 88(21):1580-6. PubMed ID: 8901856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.
    Ahomadegbe JC; Barrois M; Fogel S; Le Bihan ML; Douc-Rasy S; Duvillard P; Armand JP; Riou G
    Oncogene; 1995 Mar; 10(6):1217-27. PubMed ID: 7700647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [p53 mutations and HPV infections in squamous epithelial carcinomas of the head-neck region. Long-term follow-up].
    Riethdorf S; Friedrich RE; Sühwold J; Ostwald C; Barten M; Gogacz P; Gundlach KK; Schlechte H; Becker J; Bregenzer T; Riethdorf L; Löning T
    Mund Kiefer Gesichtschir; 1998 Jan; 2(1):30-4. PubMed ID: 9522570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers.
    Kropveld A; Rozemuller EH; Leppers FG; Scheidel KC; de Weger RA; Koole R; Hordijk GJ; Slootweg PJ; Tilanus MG
    Lab Invest; 1999 Mar; 79(3):347-53. PubMed ID: 10092071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of the p53 gene status of lymph node metastasis in the head and neck region in occult primary cancer].
    Gottschlich S; Schuhmacher O; Görögh T; Hoffmann M; Maune S
    Laryngorhinootologie; 2000 Jul; 79(7):434-7. PubMed ID: 11005098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53 tumor suppressor gene mutations in laryngeal cancer and in recurrent disease following radiation therapy.
    Tjebbes GW; Kreijveld PA; Tilanus MG; Hordijk GJ; Slootweg PJ
    Oral Oncol; 2002 Apr; 38(3):296-300. PubMed ID: 11978553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of the p53 gene predicts lymph node metastases in Japanese patients with esophageal carcinoma: DNA and immunohistochemical analyses.
    Hattori K; Kajiyama Y; Tsurumaru M
    Dis Esophagus; 2003; 16(4):301-6. PubMed ID: 14641293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mutation is rare in oral mucosa brushings from patients previously treated for a head and neck squamous cell carcinoma.
    Acha-Sagredo A; Ruesga MT; Rodriguez C; Aguirregaviria JI; de Pancorbo MM; Califano JA; Aguirre JM
    Oral Oncol; 2009 Aug; 45(8):661-4. PubMed ID: 19027352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinoma.
    el-Naggar AK; Lai S; Luna MA; Zhou XD; Weber RS; Goepfert H; Batsakis JG
    Int J Cancer; 1995 Jun; 64(3):196-201. PubMed ID: 7622308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of p53 protein is common in premalignant head and neck lesions.
    Pavelic ZP; Li YQ; Stambrook PJ; McDonald JS; Munck-Wikland E; Pavelic K; Dacic S; Danilovic Z; Pavelic L; Mugge RE
    Anticancer Res; 1994; 14(5B):2259-66. PubMed ID: 7840533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.
    Hedberg ML; Goh G; Chiosea SI; Bauman JE; Freilino ML; Zeng Y; Wang L; Diergaarde BB; Gooding WE; Lui VW; Herbst RS; Lifton RP; Grandis JR
    J Clin Invest; 2016 Jan; 126(1):169-80. PubMed ID: 26619122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 mutations in upper aerodigestive squamous cell carcinomas from a group of Brazilian patients.
    Nagai MA; Miracca EC; Yamamoto L; Kowalski LP; Brentani RR
    Am J Surg; 1995 Nov; 170(5):492-4. PubMed ID: 7485740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 gene mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: a long-term follow-up study.
    Riethdorf S; Friedrich RE; Ostwald C; Barten M; Gogacz P; Gundlach KK; Schlechte H; Becker J; Bregenzer T; Riethdorf L; Löning T
    J Oral Pathol Med; 1997 Aug; 26(7):315-21. PubMed ID: 9250931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 Mutation in histologically normal mucosa of the aero-digestive tract is not a marker of increased risk for second primary carcinoma in head and neck cancer patients.
    Escher A; Piotet E; Waridel F; Iggo R; Monnier P
    Eur Arch Otorhinolaryngol; 2009 Apr; 266(4):547-51. PubMed ID: 18688630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High incidence of p53 mutations in primary and metastatic head and neck tumors. Frequent protein overexpression in normal epithelium].
    Fogel S; Ahomadegbe JC; Barrois M; Le Bihan ML; Douc-Rasy S; Duvillard P; Armand JP; Riou G
    Bull Cancer; 1996 Mar; 83(3):227-33. PubMed ID: 8695925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.